newsfilter
← Latest News
Business Wire·

Magenta Therapeutics Appoints David Nichols as Chief Technical Officer

Magenta Therapeutics (NASDAQ:MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to more patients, today announced the appointment of David Nichols as Chief Technical Officer.